Clinical Trial Update: Study to Evaluate Benefits & Safety of Endourage Formula C™ Oral Drops in People With Post-Acute COVID-19 Syndrome. [NA]

View source ↗

Summary

A clinical trial evaluating Endourage Formula C™ Oral Drops for post-acute COVID-19 syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• Endourage Formula C™ Oral Drops

Snippet

Sponsor: Endourage, LLC | Conditions: Covid 19 | NA | Status: COMPLETED